P. T. Wright

发表

Design, Synthesis, and Structure−Activity Relationships of Novel Non-Imidazole Histamine H3 Receptor Antagonists

N. Shankley, I. Buck, S. Kalindjian, 2000 .

Novel, achiral 1,3,4-benzotriazepine analogues of 1,4-benzodiazepine-based CCK(2) antagonists that display high selectivity over CCK(1) receptors.

C. Low, C. Austin, I. Buck, 2006, Journal of medicinal chemistry.

Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists.

J. Black, C. Low, N. Shankley, 2005, Journal of medicinal chemistry.

Synthetic developments in host–guest chemistry

J. Dowden, J. Kilburn, P. T. Wright, 1994 .

A cyclobutadiene equivalent in the catalytic Pauson-Khand reaction.

S. Gibson, S. Kalindjian, P. T. Wright, 2004, Angewandte Chemie.

Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists.

C. Low, C. Austin, D. Sykes, 2007, Journal of medicinal chemistry.

Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion.

J. Black, D. Sykes, I. Buck, 2007, Journal of medicinal chemistry.

A new class of non-racemic chiral macrocycles: a conformational and synthetic study.

A. White, S. Gibson, S. Kalindjian, 2004, Chemistry.

Synthesis of cyclic sulfonamides through intramolecular Diels-Alder reactions.

I. Greig, M. Tozer, P. T. Wright, 2001, Organic letters.

Repositioned Drugs for COVID-19—the Impact on Multiple Organs

Weiyang Yang, Wen Li, P. T. Wright, 2021, SN Comprehensive Clinical Medicine.

Synthesis of meta- and paracyclophanes containing unsaturated amino acid residues

J. Steed, M. Tozer, S. Gibson, 2004 .

A versatile approach to chiral macrocycles

S. Gibson, S. Kalindjian, P. T. Wright, 2003 .

A Cyclobutadiene Equivalent in the Catalytic Pauson—Khand Reaction.

S. Gibson, S. Kalindjian, P. T. Wright, 2005 .